Epogen Facing Sales Hit With Reduced Dosing Instructions In ESA Labeling For Renal Disease

Amgen agrees to studies to find what FDA calls "better, safer dose regimen strategies" as ESA labeling revisions create more conservative dosing guidelines for the products.